Catherine A. Rugg

3.3k total citations · 1 hit paper
17 papers, 2.8k citations indexed

About

Catherine A. Rugg is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Catherine A. Rugg has authored 17 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Catherine A. Rugg's work include Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (3 papers) and Cancer Genomics and Diagnostics (3 papers). Catherine A. Rugg is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (3 papers) and Cancer Genomics and Diagnostics (3 papers). Catherine A. Rugg collaborates with scholars based in United States, Australia and Belgium. Catherine A. Rugg's co-authors include David W. Hedley, Ian W. Taylor, Elizabeth A. Musgrove, Michael Friedländer, Richard D. Gelber, Stuart L. Emanuel, Steven A. Middleton, Alan B. P. Ng, Angel R. Fuentes‐Pesquera and Peter J. Connolly and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Molecular Pharmacology.

In The Last Decade

Catherine A. Rugg

17 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

1983 1.8k citations David W. Hedley, Michael Friedländer et al. Journal of Histochemistry & Cytochemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine A. Rugg United States	16	982	942	750	708	628	17	2.8k
J. M. Nesland Norway	31	1.5k 1.5×	945 1.0×	1.1k 1.5×	349 0.5×	780 1.2×	59	3.0k
Diane L. Persons United States	29	1.3k 1.3×	608 0.6×	1.4k 1.8×	398 0.6×	409 0.7×	64	3.1k
Emiliano Cocco United States	32	1.6k 1.6×	532 0.6×	1.1k 1.5×	442 0.6×	833 1.3×	83	3.2k
José A. Martínez-Climent Spain	39	1.3k 1.3×	784 0.8×	1.9k 2.5×	1.0k 1.5×	483 0.8×	135	4.5k
Maryse Fiche France	29	1.6k 1.7×	976 1.0×	1.2k 1.6×	543 0.8×	711 1.1×	83	3.4k
Farbod Darvishian United States	37	1.9k 1.9×	1.2k 1.3×	2.4k 3.2×	496 0.7×	543 0.9×	119	4.3k
Judith Hugh Canada	25	2.2k 2.2×	2.0k 2.1×	1.4k 1.9×	920 1.3×	701 1.1×	50	4.4k
Sherri Z. Millis United States	25	1.1k 1.1×	421 0.4×	772 1.0×	360 0.5×	852 1.4×	93	2.3k
John F. Lyons United States	32	1.3k 1.3×	551 0.6×	2.7k 3.6×	385 0.5×	454 0.7×	81	4.3k
Carla Boccaccio Italy	33	1.4k 1.5×	809 0.9×	2.1k 2.8×	471 0.7×	518 0.8×	63	4.2k

Countries citing papers authored by Catherine A. Rugg

Since Specialization

Citations

This map shows the geographic impact of Catherine A. Rugg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Rugg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Rugg more than expected).

Fields of papers citing papers by Catherine A. Rugg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Rugg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Rugg. The network helps show where Catherine A. Rugg may publish in the future.

Co-authorship network of co-authors of Catherine A. Rugg

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. Rugg. A scholar is included among the top collaborators of Catherine A. Rugg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. Rugg. Catherine A. Rugg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rugg, Catherine A., Julie White, Jason T. Ross, et al.. (2016). Pharmacological evaluation of a selective bradykinin B₁antagonist in a canine model of arthritis. Journal of Veterinary Pharmacology and Therapeutics. 40(1). 70–76. 1 indexed citations

Peppard, Jane, et al.. (2014). Identifying Small Molecules which Inhibit Autophagy: a Phenotypic Screen Using Image-Based High-Content Cell Analysis. PubMed. 8(1). 3–15. 28 indexed citations

Peppard, Jane, Catherine A. Rugg, Elaine A. Powers, et al.. (2014). High-Content Phenotypic Screening and Triaging Strategy to Identify Small Molecules Driving Oligodendrocyte Progenitor Cell Differentiation. SLAS DISCOVERY. 20(3). 382–390. 16 indexed citations

McCandless, Erin E., et al.. (2013). Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells. Veterinary Immunology and Immunopathology. 157(1-2). 42–48. 37 indexed citations

Hughes, Terry V., Stuart L. Emanuel, Peter J. Connolly, et al.. (2008). 7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: Design, synthesis, and biological activity. Bioorganic & Medicinal Chemistry Letters. 18(18). 5130–5133. 16 indexed citations

Emanuel, Stuart L., Terry V. Hughes, Mary Adams, et al.. (2007). Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors. Molecular Pharmacology. 73(2). 338–348. 30 indexed citations

Rugg, Catherine A., Stuart L. Emanuel, Anna Maria Calcagno, et al.. (2006). Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor. Molecular Cancer Therapeutics. 5(10). 2459–2467. 47 indexed citations

Emanuel, Stuart L., Catherine A. Rugg, Robert H. Gruninger, et al.. (2005). The In vitro and In vivo Effects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases. Cancer Research. 65(19). 9038–9046. 101 indexed citations

Kuo, Gee‐Hong, Stuart L. Emanuel, Aihua Wang, et al.. (2005). Synthesis and Identification of [1,3,5]Triazine-pyridine Biheteroaryl as a Novel Series of Potent Cyclin-Dependent Kinase Inhibitors. Journal of Medicinal Chemistry. 48(14). 4535–4546. 72 indexed citations

10.

Lin, Ronghui, Peter J. Connolly, Shenlin Huang, et al.. (2005). 1-Acyl-1H-[1,2,4]triazole-3,5-diamine Analogues as Novel and Potent Anticancer Cyclin-Dependent Kinase Inhibitors: Synthesis and Evaluation of Biological Activities. Journal of Medicinal Chemistry. 48(13). 4208–4211. 109 indexed citations

11.

Hedley, David W., Catherine A. Rugg, & Richard D. Gelber. (1987). Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.. PubMed. 47(17). 4729–35. 230 indexed citations

12.

Musgrove, Elizabeth A., Catherine A. Rugg, & David W. Hedley. (1986). Flow cytometric measurement of cytoplasmic pH: A critical evaluation of available fluorochromes. Cytometry. 7(4). 347–355. 104 indexed citations

13.

Hedley, David W., Catherine A. Rugg, Elizabeth A. Musgrove, & Ian W. Taylor. (1985). Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis. Journal of Cellular Physiology. 124(1). 61–66. 19 indexed citations

14.

Hedley, David W., Catherine A. Rugg, Alan B. P. Ng, & Ian W. Taylor. (1984). Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.. PubMed. 44(11). 5395–8. 129 indexed citations

15.

Musgrove, Elizabeth A., Catherine A. Rugg, Ian W. Taylor, & David W. Hedley. (1984). Transferrin receptor expression during exponential and plateau phase growth of human tumour cells in culture. Journal of Cellular Physiology. 118(1). 6–12. 54 indexed citations

16.

Hedley, David W., Jeanette Philips, Catherine A. Rugg, & Ian W. Taylor. (1984). Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions. European Journal of Cancer and Clinical Oncology. 20(6). 749–752. 32 indexed citations

17.

Hedley, David W., Michael Friedländer, Ian W. Taylor, Catherine A. Rugg, & Elizabeth A. Musgrove. (1983). Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.. Journal of Histochemistry & Cytochemistry. 31(11). 1333–1335. 1806 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact